High body mass index and pre-existing autoimmune disease are associated with an increased risk of immune-related adverse events in cancer patients treated with PD-(L)1 inhibitors a...

por Gülave, B., Hew, M.N., de Groot, J.S., Rodwell, L., Teerenstra, S., Fabriek, B.O.
Publicado 2021